Next Article in Journal
Identification and Characterization of Potential Impurities in Raloxifene Hydrochloride
Previous Article in Journal
Simultaneous Estimation of Amlodipine Besylate and Indapamide in a Pharmaceutical Formulation by a High Performance Liquid Chromatographic (RP-HPLC) Method
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product

by
Rakshit Kanubhai TRIVEDI
1,2,*,
Dhairyshil S. CHENDAKE
1 and
Mukesh C. PATEL
2
1
Analytical Research and Development, Integrated Product Development, Dr. Reddy’s Laboratories Ltd.,Bachupally, Hyderabad-500 072, India
2
Science and H. D. Patel Arts College, S. V. Campus, Kadi-382 715, Gujarat, India
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2012, 80(3), 591-604; https://doi.org/10.3797/scipharm.1204-06
Submission received: 9 April 2012 / Accepted: 22 May 2012 / Published: 22 May 2012

Abstract

A stability-indicating reversed-phase high performance liquid chromatography (RP-HPLC) method was developed for the simultaneous determination of Formoterol fumarate (FOR), Tiotropium bromide (TRI), and Ciclesonide (CLS) in a pulmonary drug product. The desired chromatographic separation was achieved on the Zorbax SB C8, 5 μm (150 x 4.6 mm) column, using gradient elution at 230 nm detector wavelength. The optimized mobile phase consisted of a 0.2 % v/v perchloric acid as solvent-A and acetonitrile as solvent-B. The developed method separated FOR, TRI, and CLS in the presence of its five unknown degradation products within 10 minutes. The stability-indicating capability was established by forced degradation experiments and the separation of unknown degradation products. The developed RP-HPLC method was validated according to the International Conference on Harmonization (ICH) guidelines. This validated method was applied for the simultaneous estimation of FOR, TRI, and CLS in commercially available Triohale® pMDI (Pressurized Metered-Dose Inhaler) samples. Furthermore, this method can be extended for individual estimation of FOR, TRI, and CLS in various commercially available pulmonary dosage forms.
Keywords: Method validation; Forced degradation; Method development; Assay; Aerosol drug product; Pressurized metered-dose inhaler; Chromatography Method validation; Forced degradation; Method development; Assay; Aerosol drug product; Pressurized metered-dose inhaler; Chromatography

Share and Cite

MDPI and ACS Style

TRIVEDI, R.K.; CHENDAKE, D.S.; PATEL, M.C. A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product. Sci. Pharm. 2012, 80, 591-604. https://doi.org/10.3797/scipharm.1204-06

AMA Style

TRIVEDI RK, CHENDAKE DS, PATEL MC. A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product. Scientia Pharmaceutica. 2012; 80(3):591-604. https://doi.org/10.3797/scipharm.1204-06

Chicago/Turabian Style

TRIVEDI, Rakshit Kanubhai, Dhairyshil S. CHENDAKE, and Mukesh C. PATEL. 2012. "A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product" Scientia Pharmaceutica 80, no. 3: 591-604. https://doi.org/10.3797/scipharm.1204-06

APA Style

TRIVEDI, R. K., CHENDAKE, D. S., & PATEL, M. C. (2012). A Rapid, Stability-Indicating RP-HPLC Method for the Simultaneous Determination of Formoterol Fumarate, Tiotropium Bromide, and Ciclesonide in a Pulmonary Drug Product. Scientia Pharmaceutica, 80(3), 591-604. https://doi.org/10.3797/scipharm.1204-06

Article Metrics

Back to TopTop